FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085642012> ?p ?o ?g. }

• W2085642012 endingPage "476" @default.
• W2085642012 startingPage "472" @default.
• W2085642012 abstract "Prognosis of metastatic renal cell carcinoma (RCC) remains highly unfavorable. Treatment with chemotherapeutic agents, radiation or hormones has been largely unsuccessful. The natural history of renal cell carcinoma is highly variable and may be characterized by late relapse after nephrectomy, prolonged stabilization of metastatic disease, and spontaneous regression. These features suggest that host immune mechanisms play an important role in the regulation of tumor growth. Hence, therapeutic strategies including cytokines, adoptive immunotherapy, gene therapy, and monoclonal antibodies (MAB) are being evaluated, aiming at modulating the host immune response. Interferons (IFN) have been widely used in the treatment of metastatic renal cell carcinoma, objective responses are achieved in approximately 12%, but complete remissions are rare. Treatment with high-dose intravenous interleukin-2 (IL-2) results in higher response rates but is associated with considerable toxicity. Combination therapy with IFN-α and IL-2 is clinically more effective than single-agent treatment. Multidrug regimens adding 5-fluoro-uracil and 13-cis-retinoic acid to the IFN-α / IL-2 combination show encouraging results. Preliminary data from trials with tumor-infiltrating lymphocytes (TIL), autolymphocyte therapy with activated memory-T cells (ALT), ex vivo primed cytotoxic T cells (CTL) or dendritic cells are promising. In gene therapy, ex vivo gene transfer into tumor cells subsequently serving as a tumor cell vaccine is investigated. In addition, intralesional in vivo gene therapy is examined in an effort to boost immunogenicity of the tumor cells. A monoclonal antibody (G250) against RCC cells has been developed and is evaluated for its diagnostic and therapeutic potential. Despite all efforts, curative results are still rare and a standard therapy for metastatic RCC is not available. If palliation is not reliably achieved with systemic therapy, tumor-related symptoms must be approached with aggressive supportive therapy. Therapy-related impact on the quality of life will become an increasingly important issue. All patients should be treated in the context of controlled studies whenever possible since, despite the encouraging results of new treatment strategies, their further assessment in large randomized trials remains a priority." @default.
• W2085642012 created "2016-06-24" @default.
• W2085642012 creator A5068927061 @default.
• W2085642012 creator A5069958862 @default.
• W2085642012 date "1999-01-01" @default.
• W2085642012 modified "2023-09-27" @default.
• W2085642012 title "Treatment Strategies in Metastatic Renal Cell Carcinoma" @default.
• W2085642012 cites W130882478 @default.
• W2085642012 cites W1484121218 @default.
• W2085642012 cites W1502100938 @default.
• W2085642012 cites W1543053385 @default.
• W2085642012 cites W1563295247 @default.
• W2085642012 cites W1578341569 @default.
• W2085642012 cites W1610624614 @default.
• W2085642012 cites W181147267 @default.
• W2085642012 cites W186894364 @default.
• W2085642012 cites W1882926415 @default.
• W2085642012 cites W1942070062 @default.
• W2085642012 cites W1945613220 @default.
• W2085642012 cites W1964312509 @default.
• W2085642012 cites W1966497667 @default.
• W2085642012 cites W1969753550 @default.
• W2085642012 cites W1972054682 @default.
• W2085642012 cites W1977823544 @default.
• W2085642012 cites W1978162502 @default.
• W2085642012 cites W1987362066 @default.
• W2085642012 cites W1991148746 @default.
• W2085642012 cites W1997448708 @default.
• W2085642012 cites W2010922182 @default.
• W2085642012 cites W2016745121 @default.
• W2085642012 cites W2025766623 @default.
• W2085642012 cites W2031841138 @default.
• W2085642012 cites W2033316540 @default.
• W2085642012 cites W2039686376 @default.
• W2085642012 cites W2040848265 @default.
• W2085642012 cites W2053958256 @default.
• W2085642012 cites W2071837442 @default.
• W2085642012 cites W2080899183 @default.
• W2085642012 cites W2085925464 @default.
• W2085642012 cites W2088234126 @default.
• W2085642012 cites W2088676895 @default.
• W2085642012 cites W2091909257 @default.
• W2085642012 cites W2095637914 @default.
• W2085642012 cites W2124376809 @default.
• W2085642012 cites W2142166250 @default.
• W2085642012 cites W2172404604 @default.
• W2085642012 cites W2224128977 @default.
• W2085642012 cites W2231346794 @default.
• W2085642012 cites W2252336676 @default.
• W2085642012 cites W2258952251 @default.
• W2085642012 cites W2334694951 @default.
• W2085642012 cites W2399474082 @default.
• W2085642012 cites W2409200492 @default.
• W2085642012 cites W2411970389 @default.
• W2085642012 cites W2416385708 @default.
• W2085642012 cites W2419175454 @default.
• W2085642012 cites W2423315740 @default.
• W2085642012 cites W2768600953 @default.
• W2085642012 cites W83138054 @default.
• W2085642012 cites W99378550 @default.
• W2085642012 doi "https://doi.org/10.1159/000027024" @default.
• W2085642012 hasPublicationYear "1999" @default.
• W2085642012 type Work @default.
• W2085642012 sameAs 2085642012 @default.
• W2085642012 citedByCount "2" @default.
• W2085642012 crossrefType "journal-article" @default.
• W2085642012 hasAuthorship W2085642012A5068927061 @default.
• W2085642012 hasAuthorship W2085642012A5069958862 @default.
• W2085642012 hasConcept C143998085 @default.
• W2085642012 hasConcept C150903083 @default.
• W2085642012 hasConcept C203014093 @default.
• W2085642012 hasConcept C207001950 @default.
• W2085642012 hasConcept C26291073 @default.
• W2085642012 hasConcept C2776090121 @default.
• W2085642012 hasConcept C2777472916 @default.
• W2085642012 hasConcept C2777701055 @default.
• W2085642012 hasConcept C2780868878 @default.
• W2085642012 hasConcept C502942594 @default.
• W2085642012 hasConcept C71924100 @default.
• W2085642012 hasConcept C86803240 @default.
• W2085642012 hasConcept C8891405 @default.
• W2085642012 hasConcept C90375314 @default.
• W2085642012 hasConceptScore W2085642012C143998085 @default.
• W2085642012 hasConceptScore W2085642012C150903083 @default.
• W2085642012 hasConceptScore W2085642012C203014093 @default.
• W2085642012 hasConceptScore W2085642012C207001950 @default.
• W2085642012 hasConceptScore W2085642012C26291073 @default.
• W2085642012 hasConceptScore W2085642012C2776090121 @default.
• W2085642012 hasConceptScore W2085642012C2777472916 @default.
• W2085642012 hasConceptScore W2085642012C2777701055 @default.
• W2085642012 hasConceptScore W2085642012C2780868878 @default.
• W2085642012 hasConceptScore W2085642012C502942594 @default.
• W2085642012 hasConceptScore W2085642012C71924100 @default.
• W2085642012 hasConceptScore W2085642012C86803240 @default.
• W2085642012 hasConceptScore W2085642012C8891405 @default.
• W2085642012 hasConceptScore W2085642012C90375314 @default.
• W2085642012 hasIssue "6" @default.
• W2085642012 hasLocation W20856420121 @default.

• next